Diclocil 1 g Nórsko - nórčina - Statens legemiddelverk

diclocil 1 g

bristol-myers squibb ab - dikloksacillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 1 g

Pravachol 40 mg Nórsko - nórčina - Statens legemiddelverk

pravachol 40 mg

bristol-myers squibb ab - pravastatin - tablett - 40 mg

Pravachol 20 mg Nórsko - nórčina - Statens legemiddelverk

pravachol 20 mg

bristol-myers squibb ab - pravastatin - tablett - 20 mg

Pentrexyl 1 g Nórsko - nórčina - Statens legemiddelverk

pentrexyl 1 g

bristol-myers squibb ab - ampicillin - pulver til injeksjons-/infusjonsvæske, oppløsning - 1 g

Pentrexyl 2 g Nórsko - nórčina - Statens legemiddelverk

pentrexyl 2 g

bristol-myers squibb ab - ampicillin - pulver til injeksjons-/infusjonsvæske, oppløsning - 2 g

Pentrexyl 500 mg Nórsko - nórčina - Statens legemiddelverk

pentrexyl 500 mg

bristol-myers squibb ab - ampicillin - pulver til injeksjons-/infusjonsvæske, oppløsning - 500 mg

Onureg Európska únia - nórčina - EMA (European Medicines Agency)

onureg

bristol-myers squibb pharma eeig - azacitidin - leukemi, myeloid, akutt - antineoplastiske midler - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).

Abecma Európska únia - nórčina - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastiske midler - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Iverpraz vet 18.7 mg / 140.3 mg Nórsko - nórčina - Statens legemiddelverk

iverpraz vet 18.7 mg / 140.3 mg

norbrook laboratories (ireland) limited - ivermektin / prazikvantel - oralpasta - 18.7 mg / 140.3 mg

Nulojix Európska únia - nórčina - EMA (European Medicines Agency)

nulojix

bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunsuppressive - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.